Related Experiment Video
Updated: Apr 19, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Cancer vaccines: what do we need to measure in clinical trials?
1a Celltrion Inc ; Incheon , South Korea.
Abstract:
Cancer immunotherapy has seen a tremendous number of failures and only few recent regulatory successes. This review is dedicated to evaluate remaining challenges in capturing clinical response with cancer vaccines. Definition of disease progression in context of clinical rather image-specific criteria and interpretation of efficacy in relation to delayed effect of cancer vaccines should be taken into account in the design of future of immunotherapy trials.
Insights
Cancer vaccines face challenges in demonstrating efficacy. Future trials must consider clinical disease progression and delayed responses for accurate immunotherapy assessment.
Area of Science:
- Oncology
- Immunology
Background:
- Cancer immunotherapy has a high failure rate, with limited regulatory successes.
- Cancer vaccines represent a promising but challenging area within immunotherapy.
Purpose of the Study:
- To evaluate the challenges in assessing clinical response to cancer vaccines.
- To inform the design of future cancer immunotherapy trials.
Main Methods:
- Review of existing literature on cancer vaccine clinical trials.
- Analysis of criteria for defining disease progression and efficacy.
Main Results:
- Current methods for capturing clinical response are insufficient for cancer vaccines.
- Image-specific criteria may not adequately reflect therapeutic effects.
Conclusions:
- Future immunotherapy trials require refined definitions of disease progression.
- Interpreting efficacy must account for the delayed effects characteristic of cancer vaccines.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
01:21Cancer Survival Analysis
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies